Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Romosozumab, ATC M05BX06 für die Zeit 01.04.2025 - 31.03.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Romosozumab, ATC M05BX06 für die Zeit 01.04.2025…”. Bids close on 5 February 2027.
The work
Non-exclusive discount agreement for Romosozumab (ATC M05BX06) for 01.04.2025 - 31.03.2027
- DAK-Gesundheit's contractual terms and specified discounts
Key facts
- Contract period
- 01.04.2025 - 31.03.2027
What it takes to qualify
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Offer letterElectronic submission via email
- Acknowledgment of contractual termsSigned contract with company name or stamp
- Annexes 1 and 2 to the contractExcel file with drug entries